ATE82959T1 - N-(2-alkyl-3-mercapto-1,5-dioxoalkyl)glycinamid derivate und deren verwendung als kollagenaseinhibitoren. - Google Patents

N-(2-alkyl-3-mercapto-1,5-dioxoalkyl)glycinamid derivate und deren verwendung als kollagenaseinhibitoren.

Info

Publication number
ATE82959T1
ATE82959T1 AT88312043T AT88312043T ATE82959T1 AT E82959 T1 ATE82959 T1 AT E82959T1 AT 88312043 T AT88312043 T AT 88312043T AT 88312043 T AT88312043 T AT 88312043T AT E82959 T1 ATE82959 T1 AT E82959T1
Authority
AT
Austria
Prior art keywords
alkyl
hydrogen
optionally substituted
dioxoalkyl
mercapto
Prior art date
Application number
AT88312043T
Other languages
English (en)
Inventor
Roger Edward Markwell
Stephen Allen Smith
Ian Hughes
Laramie Mary Gaster
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Application granted granted Critical
Publication of ATE82959T1 publication Critical patent/ATE82959T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/24—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/25—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/20—Esters of monothiocarboxylic acids
    • C07C327/32—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/22—Radicals substituted by singly bound oxygen or sulfur atoms etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT88312043T 1987-12-22 1988-12-19 N-(2-alkyl-3-mercapto-1,5-dioxoalkyl)glycinamid derivate und deren verwendung als kollagenaseinhibitoren. ATE82959T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878729804A GB8729804D0 (en) 1987-12-22 1987-12-22 Novel compounds
EP88312043A EP0322184B1 (de) 1987-12-22 1988-12-19 N-(2-Alkyl-3-mercapto-1,5-dioxoalkyl)glycinamid-Derivate und deren Verwendung als Kollagenase-Inhibitoren

Publications (1)

Publication Number Publication Date
ATE82959T1 true ATE82959T1 (de) 1992-12-15

Family

ID=10628830

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88312043T ATE82959T1 (de) 1987-12-22 1988-12-19 N-(2-alkyl-3-mercapto-1,5-dioxoalkyl)glycinamid derivate und deren verwendung als kollagenaseinhibitoren.

Country Status (12)

Country Link
US (1) US5010097A (de)
EP (1) EP0322184B1 (de)
JP (1) JPH02777A (de)
KR (1) KR890009864A (de)
AT (1) ATE82959T1 (de)
AU (1) AU614003B2 (de)
DE (1) DE3876402T2 (de)
DK (1) DK709088A (de)
GB (1) GB8729804D0 (de)
NZ (1) NZ227400A (de)
PT (1) PT89263B (de)
ZA (1) ZA889477B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8921326D0 (en) * 1989-09-21 1989-11-08 Beecham Group Plc Novel treatment
GB9107367D0 (en) * 1991-04-08 1991-05-22 Smithkline Beecham Plc Novel compounds
US5340828A (en) * 1991-09-30 1994-08-23 Merck & Co., Inc. Inhibitors of farnesyl protein transferase
AU4267293A (en) * 1992-05-01 1993-11-29 British Biotech Pharmaceuticals Limited Use of MMP inhibitors
US5352705A (en) * 1992-06-26 1994-10-04 Merck & Co., Inc. Inhibitors of farnesyl protein transferase
US5831004A (en) 1994-10-27 1998-11-03 Affymax Technologies N.V. Inhibitors of metalloproteases, pharmaceutical compositions comprising same and methods of their use
US5840698A (en) * 1994-10-27 1998-11-24 Affymax Technologies N.V. Inhibitors of collagenase-1 and stormelysin-I metalloproteases, pharmaceutical compositions comprising same and methods of their use
US5932579A (en) 1996-06-18 1999-08-03 Affymax Technologies N.V. Collagenase-1 and stromelysin-1 inhibitors, pharmaceutical compositions comprising same and methods of their use
US5852213A (en) * 1996-07-10 1998-12-22 American Cyanamid Company Mercaptoketones and mercaptoalcohols and a process for their preparation
US6034136A (en) * 1997-03-20 2000-03-07 Novartis Ag Certain cyclic thio substituted acylaminoacid amide derivatives
US6448058B1 (en) 1997-09-12 2002-09-10 Versicor, Inc. Methods for solid phase synthesis of mercapto compounds and derivatives, combinatorial libraries thereof and compositions obtained thereby
CN100431985C (zh) * 2005-08-31 2008-11-12 刘天暘 湿法磷酸生产用阻垢剂
KR100900834B1 (ko) * 2008-12-03 2009-06-04 오선영 기능성 파이

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4256761A (en) * 1979-07-13 1981-03-17 Usv Pharmaceutical Corporation Antihypertensive amides
US4595700A (en) * 1984-12-21 1986-06-17 G. D. Searle & Co. Thiol based collagenase inhibitors
US4681966A (en) * 1985-02-21 1987-07-21 G. D. Searle & Co. Intermediate for thiol based collagenase inhibitors
AU599736B2 (en) * 1986-12-24 1990-07-26 Beecham Group Plc Thiol-carboxylic acid derivatives

Also Published As

Publication number Publication date
DK709088D0 (da) 1988-12-20
AU614003B2 (en) 1991-08-15
PT89263B (pt) 1993-07-30
EP0322184A3 (en) 1990-08-29
GB8729804D0 (en) 1988-02-03
US5010097A (en) 1991-04-23
DE3876402D1 (de) 1993-01-14
PT89263A (pt) 1989-12-29
AU2707488A (en) 1989-06-22
DK709088A (da) 1989-06-23
EP0322184A2 (de) 1989-06-28
EP0322184B1 (de) 1992-12-02
DE3876402T2 (de) 1993-05-06
ZA889477B (en) 1989-10-25
KR890009864A (ko) 1989-08-04
JPH02777A (ja) 1990-01-05
NZ227400A (en) 1991-07-26

Similar Documents

Publication Publication Date Title
DK633088A (da) Kollagenaseinhibitorer
DE3876402D1 (de) N-(2-alkyl-3-mercapto-1,5-dioxoalkyl)glycinamid-derivate und deren verwendung als kollagenase-inhibitoren.
DE3782687D1 (de) Aminoimidazochinolin-derivate.
DE68908643D1 (de) Mercapto-phenylalkanoylaminosäure-Amide, deren Herstellung und deren Verwendung als Collagenase-Inhibitoren.
EA200001165A1 (ru) Производные тетрагидрохинолина в качестве антагонистов глицина
SE8303913D0 (sv) Heterocykliska foreningar
ES527739A0 (es) Un procedimiento para preparar derivados de pirimidina
NO865228D0 (no) Tetrahydropyranderivater og fremgangsmaate for fremstilling derav.
ATE8633T1 (de) Vinyl-3-cephalosporinverbindungen und ihre herstellung.
DE3070032D1 (en) Aminoalkyl benzofuran derivatives, their production and compositions containing them
DK370380A (da) Beta-carbolin-3-carboxylsyrederivater og fremgangsmaader til fremstilling af samme
MX9201575A (es) Compuestos novedosos.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties